Kyle Rose
Stock Analyst at Canaccord Genuity
(2.67)
# 2,150
Out of 4,970 analysts
114
Total ratings
53.26%
Success rate
13.92%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNN Smith & Nephew | Maintains: Hold | $27 | $37.35 | -27.71% | 6 | Feb 26, 2025 | |
| PODD Insulet | Maintains: Buy | $304 → $324 | $343.53 | -5.69% | 16 | Feb 21, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $388.56 | +11.95% | 20 | Jan 29, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $58.80 | +20.75% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $30.66 | +131.57% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $14.51 | +51.62% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $2.00 | +400.00% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $15.90 | +38.36% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $78.92 | +90.07% | 17 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $360 → $270 | $5.84 | +4,523.29% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $16.22 | +66.46% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.65 | +809.09% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $15.61 | -3.91% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $175.13 | -30.34% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $4.09 | -2.20% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.04 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $105.04 | +19.00% | 7 | Feb 8, 2022 |
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $37.35
Upside: -27.71%
Insulet
Feb 21, 2025
Maintains: Buy
Price Target: $304 → $324
Current: $343.53
Upside: -5.69%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $388.56
Upside: +11.95%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $58.80
Upside: +20.75%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $30.66
Upside: +131.57%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $14.51
Upside: +51.62%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $2.00
Upside: +400.00%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $15.90
Upside: +38.36%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $78.92
Upside: +90.07%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $5.84
Upside: +4,523.29%
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $16.22
Upside: +66.46%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $1.65
Upside: +809.09%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $15.61
Upside: -3.91%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $175.13
Upside: -30.34%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $4.09
Upside: -2.20%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $7.04
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $105.04
Upside: +19.00%